Company Monitoring Page for Eisai

latest headlines for company on cafepharma

Gilead gets ball rolling on JAKs game in Japan
Endpoints
Mon, 12/30/19 - 10:39 am
Tags:
Gilead Sciences, Japan, filgotinib, Eisai, rheumatoid arthritis
Eisai preps for launch with insomnia med Dayvigo after buying out Purdue
Fierce Pharma
Mon, 12/23/19 - 11:36 pm
Tags:
Eisai, Purdue, FDA, drug launches, insomnia, Dayvigo
Dova Pharma's bet on Eisai castoff spells gold as Sobi spends millions to acquire it
Endpoints
Mon, 09/30/19 - 12:06 pm
Tags:
Dova Pharmaceuticals, Eisai, Swedish Orphan Biovitrum, M&A
ESMO: Merck, Eisai detail Keytruda-Lenvima combo results after triple endometrial cancer OK
Fierce Pharma
Sun, 09/29/19 - 09:37 pm
Tags:
Merck, Eisai, Keytruda, Lenvima, endometrial cancer, ESMO
Merck, Eisai's Keytruda-Lenvima combo wins simultaneous OKs in U.S., Canada and Australia
Fierce Pharma
Wed, 09/18/19 - 09:56 am
Tags:
Merck, Keytruda, Eisai, Lenvima, endometrial cancer, Canada, Australia
Biogen, Eisai throw out remaining Alzheimer's BACE hope
Fierce Biotech
Fri, 09/13/19 - 10:45 am
Tags:
Biogen, Eisai, Alzheimer's disease, BACE inhibitors, elenbecestat, aducanumab
Eisai launches first startup incubator under its genomics center for dementia
Fierce Biotech
Tue, 07/9/19 - 11:53 am
Tags:
Eisai, incubators, Cambridge, genomics, dementia
Schrödinger hires ex-Eisai, Merck staff for push into clinic
Fierce Biotech
Wed, 06/19/19 - 09:51 am
Tags:
Schrödinger, R&D, Eisai, Merck, biotech
Why Alzheimer's Treatment Hopes Endure Despite High-Profile Drug Failures
Investors Business Daily
Sat, 06/15/19 - 05:44 pm
Tags:
Alzheimer's disease, drug development, Biogen, Eisai
Alzheimer’s R&D projects sidelined as Biogen’s aducanumab shock shakes researchers to the core of their beliefs
Endpoints
Tue, 05/14/19 - 09:56 am
Tags:
Alzheimer's disease, drug development, aducanumab, Biogen, Eisai, BAN2401, Merck, Eli Lilly, AstraZeneca
New Eisai venture arm to focus on digital tech, dementia, cancer
BioCentury
Fri, 05/10/19 - 06:02 pm
Tags:
Eisai, venture capital, dementia, digital technology, cancer
Eisai Continues Alzheimer's Research, Adds 2 Alzheimer's Pros as Execs
BioSpace
Sun, 05/5/19 - 10:36 am
Tags:
Eisai, Biogen, Alzheimer's disease, R&D, aducanumab, BAN2401
After A Big Failure, Scientists And Patients Hunt For A New Type Of Alzheimer's Drug
NPR
Sat, 05/4/19 - 02:35 pm
Tags:
Alzheimer's disease, R&D, drug development, beta amyloid, Biogen, Eisai, aducanumab
Eisai buys Purdue stake in insomnia drug as PDUFA date nears
Fierce Biotech
Wed, 05/1/19 - 10:46 am
Tags:
Eisai, Purdue Pharma, insomnia, lemborexant, FDA
Is a severely damaged Biogen looking to shed its ties to a controversial development partner?
Endpoints
Sat, 03/23/19 - 12:07 pm
Tags:
Biogen, Eisai, Alzheimer's disease, BAN2401
RIP amyloid beta theory? Nope. Biogen partner launches a new PhIII before aducanumab's corpse turned cold
Endpoints
Fri, 03/22/19 - 11:58 am
Tags:
Biogen, Eisai, BAN2401, Alzheimer's disease, clinical trials
Biogen halts Alzheimer's drug trials in 'transformative' failure for the biotech
BioPharma Dive
Thu, 03/21/19 - 09:56 am
Tags:
Biogen, Eisai, Alzheimer's disease, clinical trials, aducanumab
Eisai, Takeda and GARDP hunt for new antibiotics
Pharmaforum
Wed, 12/12/18 - 09:54 am
Tags:
Eisai, Takeda, GARDP, antibiotics, R&D
Eisai, UCL to launch phase I trials of E2814 for Alzheimer’s disease
Pharmaceutical Business Review
Mon, 12/10/18 - 09:47 am
Tags:
Eisai, Alzheimer's disease, E2814, clinical trials, University College London
Careful, reps: Doctors are watching, FDA promo police's latest rebuke shows
Fierce Pharma
Tue, 10/30/18 - 12:15 pm
Tags:
FDA, drug reps, physicians, Eisai, Fycompa, drug marketing

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.